Stromal-epithelial cell interactions in breast cancer

Advances in Experimental Medicine and Biology

Volumn 399, Issue , 1996, Pages 41-51

  Heber, David ^a   Ashley, Judith ^a   Bagga, Dilprit ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GROWTH FACTOR;

ADIPOCYTE; BREAST CARCINOGENESIS; BREAST CARCINOMA; BREAST EPITHELIUM; BREAST METASTASIS; CANCER GROWTH; CANCER RISK; CELL INTERACTION; CELL TYPE; CONFERENCE PAPER; DIET; FEMALE; HUMAN; HUMAN CELL; OBESITY; PRIORITY JOURNAL; STROMA CELL;

EID: 0029954565     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4613-1151-5_4     Document Type: Conference Paper

References (69)

1. American Cancer Society. Cancer Facts and Figures. Atlanta, GA. American Cancer Society, 1993.
2. Feuer EJ, Wun LM, Boring CC, Flanders WD, Timmel MJ, Tong T. The lifetime risk of developing breast cancer. J Natl Cancer Inst 1993; 85:892-297.
3. Henderson BE, Bernstein L. The international variation in breast cancer rates: an epidemiological assessment. Breast Cancer Research and Treatment 1991; 18 Suppl 1:S11-17.
4. Miller AB, Bulbrook RD. UICC multidisciplinary project on breast cancer: the epidemiology, aetiology and prevention of breast cancer. Int J Cancer 1986; 37:173-177.
5. Shimizu H, Ross RK, Bernstein L, Yatani R, Henderson BE, Mack TM. Cancer of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer 1991; 63:963-966.
6. Tsugane S, de Souza JMP, Costa ML Jr, Mirra JP, Gottlieb SLD, Laurenti R, Watanabe S. Cancer incidence rates among Japanese immigrants to Sao Paulo, Brazil, 1969-1978. Cancer Causes and Control 1990; 1:189-193.
7. Kodama M, Kodama T, Miura S, Yoshida M. Nutrition and breast cancer risk in Japan. Anticancer Research 1991; 11:745-754.
8. Willett WC, Hunter DJ, Stampfer MJ et al. Dietary fat and fiber in relation to risk of breast cancer: an 8 year follow-up. JAMA 1992; 268: 2037-2044.
9. Pike MC, Spicer DV, Dahmoush L, and Press MF. Estrogens, Progestogens, normal breast cell proliferation and breast cancer risk. Epidemio Rev 1993; 15: 17-35.
10. Anderson TJ, Batterbys S, King RJB et al. Oral contraceptive use influences resting breast proliferation. Human Pathol 1989; 20: 1139-1144.
11. Klokm JGM, Berns PMJJ, van Putten WLJ, Bontenbal M et al. Critical review of growth factors as clinical tools in primary and metastatic breast cancer. Recent Results Canc Res 1993; 127:77-88.
12. Coombes RC, Barrett-Lee P, Luqmani Y. Growth factor expression in breast tissue. J Steroid Biochem Molec Biol 1990; 37: 833-837.
13. Westley BR and May FEB. Role of Insulin-like growth factor in steroid modulated proliferation. J Steroid Biochem Molec Biol 1994; 51: 1-9.
14. Freed KA, Herrington AC. Insulin-like growth factor-I and its autocrine role in growth of MCF-7 human breast cancer cells in culture. J Molec Endoc 1989; 3: 183-190.
15. Yee D, Paik S, Lebovic GS, Lippman ME et al. Analysis of insulin-like growth factor I gene expression in malignancy: evidence for a paracrine role in human breast cancer. Molec Endocr 1989; 3: 509-517.
16. Stewart AJ, Johnson MD, May FEB et al. Role of insulin-like growth factor and the type I insulin-like growth factor receptor in the estrogen stimulated proliferation of human breast cancer cells. J Biol Chem 1990; 34: 21172-21178.
17. Yee D, Cullen KJ, Paik S et al. Insulin-like growth factor -II mRNA in human breast cancer. Cancer Res 1988; 48: 6691-6696.
18. Carroll, KK, Khor HT Effect of level and type of dietary fat on incidence of mammary tumors induced in female Sprague-Dawley rats by 7,12 dimethylbenzanthracene. Lipids 1971; 6:415-419.
19. Rose DP, Connolly JM. Effects of fatty acids and inhibitors of cicosanoid synthesis on the growth of human breast cancer cell lines in culture. Cancer Res 1990; 50:7139-7144.
20. Lyons WR, Li CH, Johnson RE. The hormonal control of mammary growth and lactation. Recent Prog Hormone Res 1958; 14: 219-254.
21. Decks S, Richards J, Nandi S. Maintainance of normal rat mammary epithelial cells by insulin and insulin-like growth factor I. Exp Cell Res 1988; 174: 448-460.
22. Sheffield LG and Welsh CW. Transplantation of human breast epithelia to mammary-gland-free fat pads of athymic nude mice: influence of mammographic hormones on growth of breast epithelia. Int J Cancer 1988; 41: 713-719.
23. Ailhaud G, Grimaldi P and Negrel R. Cellular and molecular aspects of adipose tissue development. Ann Rev Nutr 1992; 12: 207-33.
24. Cornelius P, MacDougald OA, Lane MD. Regulation of adipocyte development. Ann Rev Nutr 1994; 14: 99-129.
25. Amri EZ, Ailhaud G, Grimaldi PA. Fatty acids as signal transducing molecules: involvement in differentiation of preadipose to adipose cells. J Lipid Res 1994; 35: 930-937.
26. Labrie F, Simard J, Luu-The V, Trudel C, Martel C et al. Expression of 3beta-hydroxysteroid dehydrogenase/delta4-delta5 isomerase (3 beta-HSD) and 17 beta-hydroxysteroid dehydrogenase (17 beta-HSD) in adipose tissue. Int J Obes 1991; 15: 91-99.
27. Boyd NF, O'Sullivan B, Campbell JE et al. Mammographic signs as risk factors for breast cancer. Br J Cancer 1982; 45: 185-193.
28. Bouchard C, Bray GA, Hubbard vs. Basic and clinical aspects of regional body fat distribution. Am J Clin Nutr 1990; 52:946-950.
29. Schapira DV, Clark RA, Wolff PA, Jarrett AR, Kumar NB, Aziz NM. Visceral obesity and breast cancer risk. Cancer 1994; 74:632-639.
30. Bernstein L, Henderson BE, Hanisch R, Sullivan-Halley, Ross RK. Physical exercise and reduced risk of breast cancer in young women. J Natl Cancer Inst 1994; 86: 1403-1408.
31. Goldin JM, Siiteri PK, MacDonald PC. Source of estrogen production in postmenopausal women. J Clin Endocrinol Metab 1973; 36:207-210.
32. Siiteri PK, MacDonald PC. Role of extraglandular estrogen in human endocrinology. In: Greep RO, Astwood EB, eds. Handbook of Physiology Sec. 7, vol.2, part 1 Wash. D.C. Am Physiol Soc 1973; 15: 629.
33. Schindler AE, Ebert A, Friedrich E. Conversion of androstenedione to estrone by human fat tissue. J Clin Endo Metab 1972; 35:627-630.
34. Simpson ER, Ackerman GE, Smith ME. Estrogen formation in stromal cells of adipose tissue of women: induction by glucocorticoids. Proc Nat Acad Sci 1981; 73:5690-5694.
35. Heber D, Koziol BJ, Shoshani A, Su SY, Colburn J, Rosser RJ, Waisman J, and Silverstein M. Regulation of breast tissue estrogen production by tumor-associated rat and human stromal fibroblasts: cell culture studies. Abst. 69th Annual Mtg. of the Endocrine Society. The Endocrine Society, Rockville, MD 1987.
36. Zumoff B. Relationship of obesity to blood estrogens. Cancer Res.(suppl) 1982; 42:3289-3294.
37. Kalish L. Relationship of body size with breast cancer. J Clin Oncol 1984; 2:287-293.
38. Abe R, Kumagai N, Kimura M. Biological characteristics of breast cancer in obesity. Tohoku J Exp Med 1976; 120:351-9.
39. Donegan WL, Hartz AJ, Rimm AA. The association of body weight with recurrent cancer of the breast. Cancer 1978; 41:1590-1594.
40. Howson CP, Kinne D, Wynder EL. Body weight, serum cholesterol and stage of primary breast cancer. Cancer 1986; 58:2372-2381.
41. De Waard F Epidemiology of breast cancer: a review. Eur J Clin Oncol 1983; 19:1671-1676.
42. Verreault R, Brisson J, Deschenes L, Naud F. Body weight and prognostic indicators in breast cancer. Am J Epidem 1989; 129: 260-268.
43. Ackerman GE, Smith ME, Mendelson CR, MacDonald PC, Simpson ER. Aromatization of Androstenedione by Human Adipose Stromal Cells in Monolayer Culture. J Clin Endo Metab 1981; 53: 412-417.
44. Heber, D, Ashley JM, McCarthy, WJ, Solares, ME, Leaf, DA, Chang, L-J C, and Elashoff RM. Assessment of adherence to a low fat diet for breast cancer prevention. Prev Med 1992; 21: 218-227.
45. Siiteri PK, Hammond GL, Nisker JA Increased availability of serum estrogens in breast cancer: a new hypothesis. In: Pike MC, Siiteri PK, Welsch CW, eds. Hormones and Breast Cancer. Banbury report no. 8 Cold Spring Harbor, NY. Cold Spring Harbor Laboratory, 1981;87-106.
46. Moore JW, Clark GMG, Bulbrook RD, et al. Serum concentrations of total and non-protein bound estradiol in patients with breast cancer and in normal controls. Int J Cancer 1986; 38:625-630.
47. Ota DM, Jones LA, Jackson GL, et al. Obesity, non-protein bound estradiol in the sera of breast cancer patients. Cancer 1986; 57:558-562.
48. Bruning PF, Bonfrer JMG, Hart AM. Non-protein bound oestradiol, sex hormone binding globulin, breast cancer, and breast cancer risk. Br J Cancer 1985; 51: 479-484.
49. Ernster VL, Wrensch MR, Petrakis NL, King EB, Miike R, Murai A, Goodson, WH, and Siiteri, PK. Benign and malignant breast disease: initial study results of serum and breast fluid analyses of endogenous estrogens. J Natl Cancer Inst 1987; 79:949-960.
50. Bruning PF, Bonfrer JMG. Free fatty acid concentrations correlated with the available fraction of estradiol in human plasma. Cancer Res 1986; 46:2606-2609.
51. Pardridge WM, Mietus LJ. Transport of steroid hormones through the rat blood-brain barrier. Primary role of albumin-bound hormone. J. Clin. Invest. 1979; 64:145-154.
52. Schapira DV, Kumar NB, Lyman GH Abdominal obesity and breast cancer risk. Ann Int Med 1990; 112:182-186.
53. Ballard-Barbash R, Schatzkin A, Carter CL, et al. Body fat distribution and breast cancer in the Framingham study. J Natl Cancer Inst 1990; 82:286-290.
54. Folsom AR, Kaye SA, Prineas RJ et al. Increased incidence of carcinoma of the breast associated with abdominal adiposity in postmenopausal women. Am J Epidemiol 121: 794-803.
55. Kissebah AH, Evans DJ, Peiris A, Wilson CR. Endocrine characteristics in regional obesities: role of sex steroids. In Vague J, Bjorntorp P, Guy-Grand B, eds. Metabolic complications of human obesities. Elsevier Science Publishers, Amsterdam. 1985; 115-130.
56. Schapira DV, Kumar NB, Lyman GH. Estimate of breast cancer risk reduction with weight loss. Cancer 1991; 67:2622-2625.
57. Kaye SA, Folsom AR, Soler JT, Prineas RJ, Potter JD. Associations of body mass and fat distribution with sex hormone concentrations in postmenopausal women. Int. J. Epidemiol. 1991; 20:151-156.
58. Harris RE, Namboodiri KK, Wynder E 1992 Breast cancer risk: effects of estrogen replacement therapy and body mass. J Natl Cancer Inst 1992; 84:1575-1582.
59. LeMarchand L, Kolonel LN, Earl ME, Mi M-P. Body size at different periods of life and breast cancer risk. Am J Epidemiol 1988; 128:137-152.
60. Kendall A, Levitsky D, Strupp BJ, Lissner L. Weight loss on a low fat diet: consequence of the imprecision of the control of food intake in humans. Am J Clin Nutr 1991; 53:1124-1129.
61. Hirayama T: A large scale cohort study on cancer risks by diet - with special reference to the risk reducing effects of green-yellow vegetable consumption. In Diet,Nutrition and Cancer, Y Hayashi et al eds. , Japan Sci Soc Press, Tokyo/VNU Sci Press, Utrecht 1986, pp. 41-53.
62. Adlercreutz H, Gorbach SL, Woods M et al. The relationship between estrogen levels and diets of Caucasian American and oriental immigrant women. Am J Clin Nutr 1986; 44:945-953.
63. Goldin BR, Adlercreutz H, Gorbach SL, Warram JH et al. Estrogen excretion patterns and plasma levels in vegetarian and omnivorous women. New Engl J Med 1982; 307:1542-1547.
64. Azzopardi JG. Problems in breast pathology. London: Saunders, 1979; 8-15.
65. Clemmons DR, Shaw DS. Variables controlling somatomedin production by cultured human fibroblasts. J Cell Physiol 1983; 115: 137-140.
66. Bronzert DA, Pantazis P, Antoniades HN et al. Synthesis and secretion of platelet-derived growth factor by human breat cancer cell lines. Proc Natl Acad Sci 1987; 84: 5763-5769.
67. Balun SE, Mahendroo MS, Simpson ER. Aromatase gene expression in adipose tissue: relationship to breast cancer. J Steroid Biochem Molec Bio 1994; 49: 319-326.
68. Spicer DV, Ursin G, Parisky YR, Pearce JG, Shoupe D et al. Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk. J Natl Cancer Inst 1994; 86: 431-436.
69. Johnston PG, Rondinone CM, Voeller D, Allegra CJ. Identification of a protein factor secreted by 3T3-L1 preadipocytes inhibitory for the human MCF-7 breast cancer cell line. Cancer Res 1992; 52: 6860-6865.